Copyright 2015 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
In the Original Contribution entitled “Effect of Patiromer on Serum Potassium Level in Patients With Hyperkalemia and Diabetic Kidney Disease: The AMETHYST-DN Randomized Clinical Trial” published in the July 14, 2015, issue of JAMA,1 an incorrect study drug dose appeared in a figure. In Figure 2, the starting patiromer dose reported as 16.2 in the x-axis for both stratum 1 and stratum 2 in both the left and the right plots should have appeared as 16.8. This article was corrected online.
Incorrect Dose in Figure. JAMA. 2015;314(7):731. doi:10.1001/jama.2015.9237